Clinical trial
RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides
NCT00307593 · Assistance Publique - Hôpitaux de Paris, Other · Completed
Key facts
| NCT number | NCT00307593 |
|---|---|
| Title | RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides |
| Official title | Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides With Positive ANCA After Relapse or Resistant Immunosuppressant Therapies |
| Lead sponsor | Assistance Publique - Hôpitaux de Paris, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Wegener's Granulomatosis, Churg-Strauss Syndrome, Microscopic Polyangiitis |
| Intervention type | Drug |
| Interventions | Infliximab, Rituximab |
| Enrollment | 20 |
| Start date | May 1, 2004 |
| Completion | Jun 1, 2007 |
| First posted | Mar 28, 2006 |
| Last update posted | Nov 19, 2007 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: